×
About 1,258 results

ALLMedicine™ Intracranial Tumors Center

Research & Reviews  488 results

Giant epidermoid cyst penetrating the skull: a case report and literature review.
https://doi.org/10.1080/02688697.2021.1950635
British Journal of Neurosurgery; Yufeng Z, Xiaoqing J et. al.

Jul 30th, 2021 - Intracranial epidermoid cyst is a rare pseudotumor of the nervous system, accounting for 0.2%-1.8% of all intracranial tumors. It is usually located in the cerebellopontine Angle or parasellar area, with insipid onset, slow growth and usually less...

Safety of growth hormone (GH) treatment in GH deficient children and adults treated for...
https://doi.org/10.1007/s11102-021-01173-0 10.4274/jcrpe.2017.S003 10.1210/jc.2018-01205 10.1210/jc.2019-00834 10.1016/j.canep.2019.101662 10.1016/S1470-2045(17)30186-9 10.1542/pir.2018-0192 10.1097/MOP.0b013e3282495a22 10.1080/14737175.2018.1528874 10.1016/j.ncl.2018.04.009 10.1542/pir.2016-0152 10.1055/s-2007-1025356 10.1515/jpem.1993.6.1.99 10.1210/jcem.84.6.5716 10.1016/j.jpeds.2010.02.028 10.1111/cen.13131 10.1159/000435856 10.1210/jc.2016-2046 10.1210/jc.2018-01133 10.1001/archpedi.1985.02140060029020 10.1016/s0140-6736(87)90355-2 10.1515/jpem.1997.10.1.41 10.1200/JCO.2002.09.142 10.1210/jcem.87.7.8606 10.1210/jc.2006-0656 10.1210/jc.2011-0112 10.1210/jc.2013-4159 10.1007/s40618-014-0179-1 10.1210/jc.2015-1002 10.1210/jc.2018-01189 10.1210/er.2018-00166 10.1158/1078-0432.CCR-17-0631 10.1210/jc.2009-0178 10.1530/EJE-12-0967 10.1007/s10072-015-2269-z 10.1016/j.jocn.2014.04.016 10.1016/j.wneu.2017.09.164 10.1007/s11102-006-7557-4 10.1038/nrendo.2018.22 10.1210/er.2006-0001 10.5603/EP.a2016.0053 10.1038/nrc3215 10.1007/s11357-017-9966-x 10.1074/jbc.272.18.12181 10.1155/2015/538019 10.1210/jcem.86.7.7635 10.1158/0008-5472.CAN-09-4502 10.1073/pnas.0405881101 10.1073/pnas.0406396101 10.1073/pnas.1600561113 10.1016/j.tem.2017.05.003 10.1016/j.ygcen.2014.11.004 10.1158/1078-0432.CCR-14-2518 10.1210/me.2015-1157 10.1016/j.ghir.2008.05.005 10.1054/npep.2002.0889 10.1016/S1470-2045(10)70095-4 10.1038/nrendo.2010.171 10.7326/0003-4819-149-7-200810070-00006 10.1111/j.1365-2265.2005.02404.x 10.18632/oncotarget.19186 10.1002/ijc.28589 10.1158/1055-9965.EPI-13-1210-T 10.1158/1055-9965.EPI-11-0179 10.1530/EJE-10-0859 10.1126/scitranslmed.3001845 10.1016/j.ghir.2018.03.004 10.1530/EJE-13-0389 10.1210/er.2009-0033 10.1530/EJE-16-0178 10.1016/j.pcl.2020.08.002 10.1007/s11102-008-0088-4 10.32641/rchped.v90i6.994 10.1016/s0959-8049(98)00212-3 10.1210/jc.2018-01175 10.1200/JCO.2011.37.9453 10.3389/fendo.2018.00643 10.4158/EP10391.OR 10.1002/cncr.29209 10.1002/pbc.28728 10.1016/s0936-6555(05)80744-7 10.1200/JCO.19.02361 10.1002/pbc.26180 10.18632/oncotarget.20619 10.1159/000502231 10.1159/000495760 10.1210/jc.2018-01204 10.1159/000023237 10.1159/000452150 10.1530/EJE-15-0873 10.1016/j.ijrobp.2020.09.055 10.6065/apem.2017.22.2.82 10.1007/s12020-014-0395-7 10.1038/bmt.2015.167 10.1016/S0140-6736(16)30053-8 10.1056/NEJMra1817346 10.1210/jc.2016-2118 10.1530/EJE-07-0631 10.4158/GL-2019-0405 10.1210/jc.2017-01899 10.1210/jc.2014-3525 10.1210/jc.2015-1475 10.1200/jco.2014.56.7933 10.1016/s0140-6736(13)62564-7 10.1038/nrendo.2016.45 10.1001/jama.2017.0693 10.1210/jc.2018-00665 10.1080/14740338.2020.1839410 10.1210/jc.2011-0179 10.1016/j.beem.2017.03.003 10.1210/jc.2005-2298 10.1210/jc.2010-0117 10.1186/1471-2431-8-25 10.1210/jc.2004-0832 10.1210/jcem.87.1.8146 10.1097/MPH.0b013e31821bbe7a 10.1530/EJE-11-0286 10.1530/EJE-14-1123 10.1210/jc.2010-0287 10.18632/oncotarget.13251 10.1186/s12902-020-0535-4 10.1177/2042018820943377 10.1016/S2213-8587(20)30163-7 10.1586/17446651.2015.996130 10.1210/jc.2012-2684 10.1111/cen.12691 10.1016/j.pedn.2011.12.006 10.1111/cen.13030 10.3389/fendo.2019.00416 10.1210/clinem/dgz149 10.1097/MED.0000000000000416 10.3389/fendo.2021.637209 10.1200/JCO.2011.34.6585 10.1016/S1470-2045(13)70107-4 10.1016/j.ecl.2012.07.002 10.1007/s007010050177 10.1007/s00381-008-0790-6 10.1080/08035250600577889 10.1158/1055-9965.EPI-20-0735 10.1007/s00381-019-04300-2 10.1007/s00701-020-04265-1 10.1530/EJE-12-0077 10.3171/jns.1991.74.5.0743 10.1016/1043-2760(95)00090-5 10.1111/j.1365-2265.2006.02508.x 10.1055/s-0037-1600744 10.1515/jpem.2010.150 10.1210/clinem/dgaa089 10.1046/j.1365-2265.1999.00695.x 10.1016/s0022-3476(96)70002-1 10.1159/000023133 10.3171/2016.4.PEDS16112 10.1016/j.jocn.2012.04.014 10.1227/01.NEU.0000372918.68453.5B 10.1016/j.wneu.2020.02.022 10.1530/EJE-17-0707 10.1210/jc.2017-01542 10.1007/s40618-014-0196-0 10.1210/jc.2008-0713 10.1530/EJE-12-0807 10.1530/EJE-09-0572 10.1530/eje.0.1460807 10.1530/EJE-07-0164 10.1111/j.1365-2265.2008.03391.x 10.1210/jc.2015-1764 10.1007/s12020-018-1787-x 10.1210/jc.2009-1611 10.1210/jc.2007-2673 10.1210/jc.2014-1013 10.1007/s11102-011-0347-7
Pituitary Boguszewski MCS, Cardoso-Demartini AA et. al.

Jul 26th, 2021 - Individuals surviving cancer and brain tumors may experience growth hormone (GH) deficiency as a result of tumor growth, surgical resection and/or radiotherapy involving the hypothalamic-pituitary region. Given the pro-mitogenic and anti-apoptotic...

A customized 3D implant to target laser interstitial thermal therapy ablation of a post...
https://doi.org/10.1016/j.jocn.2021.05.064
Journal of Clinical Neuroscience : Official Journal of Th... Kozlowski J, VanKoevering K et. al.

Jul 20th, 2021 - Laser interstitial thermal therapy (LITT) is a minimally invasive neurosurgical technique that has been demonstrated to successfully ablate intracranial tumors. While LITT for supratentorial lesions can often be straightforward, ablation of infrat...

Preclinical modeling in GBM PDX xenografts to guide clinical development of lisavanbuli...
https://doi.org/10.1093/neuonc/noab162
Neuro-oncology Burgenske DM, Talele S et. al.

Jul 8th, 2021 - Glioblastoma (GBM) is an incurable disease with few approved therapeutic interventions. Radiation therapy (RT) and temozolomide (TMZ) remain the standards of care. The efficacy and optimal deployment schedule of the orally bioavailable small-molec...

Optimal timing of post-operative enoxaparin after neurosurgery: A single institution ex...
https://doi.org/10.1016/j.clineuro.2021.106792
Clinical Neurology and Neurosurgery; Briggs RG, Lin YH et. al.

Jul 8th, 2021 - Venous thromboembolism (VTE) is a well-known problem in patients with intracranial tumors, especially high-grade gliomas. Optimal management of VTE complications is critical given that the development of deep vein thrombosis (DVT) and/or pulmonary...

see more →

Clinicaltrials.gov  9 results

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
https://clinicaltrials.gov/ct2/show/NCT01345136

Feb 27th, 2020 - This protocol is a Phase II, open-label, efficacy and safety study of single-agent RAD001 in patients with NF2. During the study, subjects will receive continuous daily oral treatment with RAD001 for up to 1 year or until tumor progression. Primar...

Effect of Antisecretory Factor, Given as a Food Supplement to Adult Patients With Severe Traumatic Brain Injury
https://clinicaltrials.gov/ct2/show/NCT03339505

Jan 13th, 2020 - Treatment of increased ICP, using Anti-secretory Factor, in patients with severe head trauma Brain edema, defined as an increased fluid content in either the extracellular or intracellular space, arise in both trauma and in conjunction with other ...

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
https://clinicaltrials.gov/ct2/show/NCT01222728

Dec 17th, 2019 - OBJECTIVE: The objective of this prospective observational study of intracranial tumors in patients with neurofibromatosis type 2 (NF2) is to gain insight into the use of 18F-fluoro-deoxyglucose (FDG) and 3 -deoxy-3 -18F-fluorothymidine (FLT) posi...

Application of New Technologies in the Resection of Intracranial Tumors
https://clinicaltrials.gov/ct2/show/NCT03717766

Oct 24th, 2018 - Main Outcome: To assess the effectiveness of new intraoperative technologies in the resection of intracranial tumors. Design: Prospective observational study. Method: Prospective observational study of the use and effectiveness of intraoperative n...

Head and Neck Maskless Immobilization Device in Immobilizing Patients With Intracranial Tumors Undergoing Radiation Therapy
https://clinicaltrials.gov/ct2/show/NCT03076255

May 24th, 2018 - PRIMARY OBJECTIVES: I. To assess the setup accuracy and reproducibility of the maskless immobilization device (MID) in patients undergoing brain radiation therapy (RT) for intracranial tumors. SECONDARY OBJECTIVES: I. To assess the patient comfort...

see more →

News  6 results

The Man Behind the Brain: Harvey Cushing's Legacy
https://www.staging.medscape.com/viewarticle/936873

Sep 9th, 2020 - A physician is obligated to consider more than a diseased organ, more than even the whole man — he must view the man in his world. –Harvey Williams Cushing A well-known photo of Harvey Cushing, taken by a friend in Switzerland. Source: Wikimedia C...

ASCO VTE guideline update: DOACs now an option for prevention, treatment
https://www.mdedge.com/fedprac/avaho/article/206647/thrombosis/asco-vte-guideline-update-doacs-now-option-prevention/page/0/1?channel=263

Aug 19th, 2019 - Additional updates CNS metastases. The anticoagulation recommendations were also updated to include patients with metastatic central nervous system malignancies (those with primary CNS malignancies were included previously).

Systemic Treatment of Brain Metastasis
https://www.mdedge.com/fedprac/article/88870/oncology/systemic-treatment-brain-metastasis

Nov 17th, 2014 - Cancer of the brain and central nervous system impacts patients differently from other cancers. This presentation by Peter Silberstein, MD, from the 2014 AVAHO Meeting in Portland, Oregon, explains the effects of the blood/brain barrier on chemoth.

Cerebellar Large B-cell Lymphoma: A Case Report
https://www.medscape.com/viewarticle/906321_4

Discussion PCNSL is a malignant NHL. It was first described by Bailey in 1929 as perivascular sarcoma.[5] The vast majority (90%) of cases are diffuse large B-cell lymphomas. Less common variants include Burkitt, T-cell, immunoblastic, or low-grad...

Craniopharyngioma Excision Exacerbates Metabolic Issues
https://www.mdedge.com/familymedicine/article/28369/endocrinology/craniopharyngioma-excision-exacerbates-metabolic-issues
Family Practice News; Miriam E. Tucker

TORONTO — Children who become obese following surgical removal of craniopharyngiomas exhibit more severe metabolic derangements than do equally obese children who did not have the tumors, Dr. Jill Hamilton reported at the annual joint meeting of t.

see more →